Medikit Co (TSE:7749) Altman Z-Score: 6.11 (As of Jul. 03, 2026) — 10% Below Median


TSE:7749 Medikit Co Ltd TSE:7749
90 GF Score
Price 円2,790.00
GF Value 円3,192.25
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Medikit Co Altman Z-Score?

Medikit Co TSE:7749 +0.36% 90 Altman Z-Score is 6.11 as of Jul. 03, 2026, which is 10% below its 10-year median of 6.76. GuruFocus rates TSE:7749 with a GF Score™ of 90/100 and a GF Value™ of 円3,192.25 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 807 Medical Devices & Instruments companies, Medikit Co ranks better than 70.63% on this metric.

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Good Sign:

Altman Z-score of 6.1 is strong.

Medikit Co has a Altman Z-Score of 6.11, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Medikit Co's Altman Z-Score or its related term are showing as below:

TSE:7749' s Altman Z-Score Range Over the Past 10 Years
Min: 5.47   Med: 6.76   Max: 7.66
Current: 6.1

During the past 13 years, Medikit Co's highest Altman Z-Score was 7.66. The lowest was 5.47. And the median was 6.76.


Medikit Co  (TSE:7749) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Medikit Co Altman Z-Score Related Terms


Medikit Co Altman Z-Score Historical Data

* Premium members only.

The historical data trend for Medikit Co's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medikit Co Altman Z-Score Chart

Medikit Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Altman Z-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.94 6.62 6.39 5.47 6.38

Medikit Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.47 5.68 5.99 6.57 6.38

TSE:7749 vs ISRG, BDX, MDLN: Altman Z-Score Comparison

For the Medical Instruments & Supplies subindustry, Medikit Co's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medikit Co Altman Z-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medikit Co's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Medikit Co's Altman Z-Score falls into.


TSE:7749
90GF Score
Medikit Co Ltd TSE:7749
Altman Z-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medikit Co Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Medikit Co's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.5238+1.4*0.7313+3.3*0.0848+0.6*6.2231+1.0*0.4464
=6.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Mar. 2026:
Total Assets was 円53,272 Mil.
Total Current Assets was 円33,215 Mil.
Total Current Liabilities was 円5,314 Mil.
Retained Earnings was 円38,958 Mil.
Pre-Tax Income was 687.341 + 1465.085 + 1264.867 + 1094.903 = 円4,512 Mil.
Interest Expense was -1.925 + -1.921 + -1.916 + -1.904 = 円-8 Mil.
Revenue was 5315.446 + 6544.096 + 6031.875 + 5890.039 = 円23,781 Mil.
Market Cap (Today) was 円40,394 Mil.
Total Liabilities was 円6,491 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(33215.017 - 5313.599)/53272.034
=0.5238

X2=Retained Earnings/Total Assets
=38957.893/53272.034
=0.7313

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(4512.196 - -7.666)/53272.034
=0.0848

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=40393.863/6491.005
=6.2231

X5=Revenue/Total Assets
=23781.456/53272.034
=0.4464

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Medikit Co has a Altman Z-Score of 6.11 indicating it is in Safe Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.

Frequently Asked Questions Learn more about Altman Z-Score →
What does a Altman Z-Score of 6.11 mean?
Medikit Co (TSE:7749) has a Altman Z-Score of 6.11 as of Jul. 03, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Medikit Co and its competitors. This is 10% below median its historical median of 6.76. Over the past decade, Medikit Co's Altman Z-Score has ranged from 5.47 to 7.66. According to the industry distribution chart, Medikit Co ranks #237 out of 807 companies in the Medical Devices & Instruments industry, placing it in the top 29.4%.
Is Medikit Co's Altman Z-Score too high?
Medikit Co's current Altman Z-Score of 6.11 is 10% below median its 10-year median of 6.76. Over the past 10 years, this metric has ranged from a low of 5.47 to a high of 7.66. The Medical Devices & Instruments industry median Altman Z-Score is 2.89. Medikit Co's value of 6.11 is 111.4% above this industry median. Based on the distribution chart, Medikit Co ranks #237 out of 807 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medikit Co has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medikit Co's Altman Z-Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Medikit Co ranks #237 out of 807 companies for Altman Z-Score. This puts Medikit Co in the upper half of its industry. The industry median Altman Z-Score is 2.89. Medikit Co's value of 6.11 is 111.4% above this benchmark. Historically, Medikit Co's own Altman Z-Score has ranged from 5.47 to 7.66 over the past decade. While the company's 10-year median is 6.76 vs. the industry median of 2.89, Medikit Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Medical Devices & Instruments company?
The median Altman Z-Score among Medical Devices & Instruments companies is 2.89, based on 807 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medikit Co's current Altman Z-Score of 6.11 is 111.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Medikit Co and its competitors. For the Medical Devices & Instruments industry, the median Altman Z-Score is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medikit Co's current Altman Z-Score is 6.11, which is 10% below median its own 10-year median of 6.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medikit Co stock overvalued right now?
Based on GuruFocus' analysis, Medikit Co (TSE:7749) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,192.25, compared to a current price of 円2,790.00 — trading 12.6% below its estimated fair value. The current Altman Z-Score is 6.11, which is 10% below median its 10-year median of 6.76 and 111.4% above the Medical Devices & Instruments industry median of 2.89. Medikit Co's overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Medikit Co (TSE:7749), the current Altman Z-Score is 6.11 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medikit Co (TSE:7749) Overvalued in 2026?

Based on GuruFocus' analysis, Medikit Co stock appears to be undervalued. The current stock price of 円2,790.00 is trading 12.6% below its estimated GF Value™ of 円3,192.25. GuruFocus considers Medikit Co to be Modestly Undervalued.

Key valuation signals for TSE:7749:

  • Altman Z-Score: 6.11 (10% below median its 10-year median of 6.76)
  • GF Value™: 円3,192.25 vs. price of 円2,790.00 (12.6% below fair value)
  • GF Score™: 90/100 with 1 warning sign
  • Industry Position: 111.4% above the Medical Devices & Instruments median (#237 of 807)

No single metric tells the full story. See the TSE:7749 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medikit Co Business Description

Address 1-13-2 ,Yushima, Bunkyo-Ku, Tokyo, JPN, 113 0034
Medikit Co Ltd develops, manufactures and sells medical equipment. The company's products offerings are IV Catheter, Hemodialysis, Inner needle, Blood control cap, among others.
90GF Score

Get the complete analysis for TSE:7749

Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,790.00
Price
円3,192.25
GF Value